Agilent Technologies Inc (NYSE:A) stock rose 6.37% (As on August 17, 11:18:47 AM UTC-4, Source: Google Finance) after the company posted better than expected results for the third quarter of FY 22 and raises the guidance for the full year. Agilent’s Life Sciences and Applied Markets Group (LSAG) reported third-quarter revenue of $1.019 billion, a year over year increase of 14% (up 18% on a core basis). LSAG’s operating margin for the quarter was 30.5%. The Agilent CrossLab Group (ACG) reported third-quarter revenue of $359 million, a year over year increase of 5% (up 10% on a core⁽¹⁾ basis). ACG’s operating margin for the quarter was 24.6%. The Diagnostics and Genomics Group (DGG) reported third-quarter revenue of $340 million, a year over year decrease of 2% (up 3% on a core basis). DGG’s operating margin for the quarter was 21.5%. Non-GAAP net income was $401 million, during the quarter, compared with $337 million during the third quarter a year ago.

A in the third quarter of FY 22 has reported the adjusted earnings per share of $1.34, beating the analysts’ estimates for the adjusted earnings per share of $1.18. The company had reported the adjusted revenue growth of 8 percent to $1.72 billion in the third quarter of FY 22, beating the analysts’ estimates for revenue of $1.61 billion. The operating income increased 22.3% Y/Y to $411 million, and the margin expanded by 275 bps to 23.9%. Agilent’s net cash provided by operating activities year-to-date was $864 million, compared to $1.04 billion a year ago. It held cash and cash equivalents of $1.07 billion as of July 31, 2022.

The outlook for fourth-quarter revenue is expected to be in a range of $1.750 billion to $1.775 billion. Fourth-quarter non-GAAP earnings guidance is expected to be in the range of $1.38 to $1.40 per share.

Full-year guidance raised with revenue now expected to be in the range of $6.750 billion to $6.775 billion, representing reported growth of 6.8% to 7.2% and core growth of 9.9% to 10.3% vs. a consensus of $6.51 billion. Full-year non-GAAP EPS is also raised to an estimated range of $5.06 to $5.08 per share vs. consensus of $4.76.

On the other hand, the company has acquired Polymer Standards Service GmbH (PSS), a provider of solutions in the field of polymer characterization. he company provides complete solutions for gel permeation chromatography (GPC) and size exclusion chromatography (SEC) used in applications to determine the molecular weight and size distribution of macromolecules.